# Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir

> **NCT01588912** · PHASE4 · UNKNOWN · sponsor: **Pusan National University Yangsan Hospital** · enrollment: 104 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Telbivudine
- **DRUG:** Tenofovir
- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT01588912
- **Lead sponsor:** Pusan National University Yangsan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2012-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588912, "Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01588912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*